13.700
+0,00%
2026-10-12
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -42.8% | -33.0% | 0 / 3 | -13.5% | -3.57 pp | -1.95 pp | +3.5% | 0.51 | 33.71 | 145 | −13,5% | 5,5 | −42,8% | 33.71 | 7.54 | +347,1% |
| Pts | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 13.700 (close price on 2026-10-12)EPS (TTM): 406,3
Financial charts
1.Revenue & growth
VND bn168Q2/26
1.Revenue & growth
VND bn168Q2/26
2.Profit & growth
VND bn6,53Q2/26
3.Profit mix (Penman)
VND bn29,4Q2/26
4.Margins & cost structure
%14.3%Q2/26
5.Returns & cash cycle
% · days4.2%Q2/26
6.Earnings quality & cash
VND bn-1,88Q2/26
7.Asset structure
VND bn943Q2/26
8.Funding & debt health
VND bn · times943Q2/26
9.Revenue backlog
VND bn32,4Q2/26
10.Valuation
times · %31,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %139Q2/26
Adjusted EPS growth, latest quarter
-32.4%
Average adjusted EPS growth, 3 quarters
-28.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26